Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Corrigendum: Operando X-Ray Absorption Spectroscopy Shows Iron Oxidation Is Concurrent with Oxygen Evolution in Cobalt-Iron (Oxy)hydroxide Electrocatalysts.

Enman LJ, Stevens MB, Dahan MH, Nellist MR, Toroker MC, Boettcher SW.

Angew Chem Int Ed Engl. 2019 Feb 11;58(7):1867. doi: 10.1002/anie.201812526. Epub 2018 Nov 14. No abstract available.

PMID:
30714687
2.

Metal Oxide/(oxy)hydroxide Overlayers as Hole Collectors and Oxygen-Evolution Catalysts on Water-Splitting Photoanodes.

Laskowski FAL, Nellist MR, Qiu J, Boettcher SW.

J Am Chem Soc. 2019 Jan 30;141(4):1394-1405. doi: 10.1021/jacs.8b09449. Epub 2018 Dec 19.

PMID:
30537811
3.

Modes of Fe Incorporation in Co-Fe (Oxy)hydroxide Oxygen Evolution Electrocatalysts.

Zhang T, Nellist MR, Enman LJ, Xiang J, Boettcher SW.

ChemSusChem. 2019 May 8;12(9):2015-2021. doi: 10.1002/cssc.201801975. Epub 2018 Nov 9.

PMID:
30371020
4.

Operando X-Ray Absorption Spectroscopy Shows Iron Oxidation Is Concurrent with Oxygen Evolution in Cobalt-Iron (Oxy)hydroxide Electrocatalysts.

Enman LJ, Stevens MB, Dahan MH, Nellist MR, Toroker MC, Boettcher SW.

Angew Chem Int Ed Engl. 2018 Sep 24;57(39):12840-12844. doi: 10.1002/anie.201808818. Epub 2018 Sep 4. Erratum in: Angew Chem Int Ed Engl. 2019 Feb 11;58(7):1867.

PMID:
30112793
5.

Structural Evolution of Metal (Oxy)hydroxide Nanosheets during the Oxygen Evolution Reaction.

Dette C, Hurst MR, Deng J, Nellist MR, Boettcher SW.

ACS Appl Mater Interfaces. 2019 Feb 13;11(6):5590-5594. doi: 10.1021/acsami.8b02796. Epub 2018 Apr 30.

PMID:
29708339
6.

Biallelic TSC2 Mutations in a Patient With Chromophobe Renal Cell Carcinoma Showing Extraordinary Response to Temsirolimus.

Maroto P, Anguera G, Roldan-Romero JM, Apellániz-Ruiz M, Algaba F, Boonman J, Nellist M, Montero-Conde C, Cascón A, Robledo M, Rodríguez-Antona C.

J Natl Compr Canc Netw. 2018 Apr;16(4):352-358. doi: 10.6004/jnccn.2017.7041.

PMID:
29632054
7.

Severe bleeding complications and multiple kidney transplants in a patient with tuberous sclerosis complex caused by a novel TSC2 missense variant.

Živčić-Ćosić S, Mayer K, Đorđević G, Nellist M, Hoogeveen-Westerveld M, Miletić D, Rački S, Klein HG, Trobonjača Z.

Croat Med J. 2017 Dec 31;58(6):416-423.

8.

Subependymal giant cell astrocytomas in Tuberous Sclerosis Complex have consistent TSC1/TSC2 biallelic inactivation, and no BRAF mutations.

Bongaarts A, Giannikou K, Reinten RJ, Anink JJ, Mills JD, Jansen FE, Spliet GMW, den Dunnen WFA, Coras R, Blümcke I, Paulus W, Scholl T, Feucht M, Kotulska K, Jozwiak S, Buccoliero AM, Caporalini C, Giordano F, Genitori L, Söylemezoğlu F, Pimentel J, Nellist M, Schouten-van Meeteren AYN, Nag A, Mühlebner A, Kwiatkowski DJ, Aronica E.

Oncotarget. 2017 Sep 8;8(56):95516-95529. doi: 10.18632/oncotarget.20764. eCollection 2017 Nov 10.

9.

Morphology Dynamics of Single-Layered Ni(OH)2/NiOOH Nanosheets and Subsequent Fe Incorporation Studied by in Situ Electrochemical Atomic Force Microscopy.

Deng J, Nellist MR, Stevens MB, Dette C, Wang Y, Boettcher SW.

Nano Lett. 2017 Nov 8;17(11):6922-6926. doi: 10.1021/acs.nanolett.7b03313. Epub 2017 Oct 11.

PMID:
28991484
10.

Direct in Situ Measurement of Charge Transfer Processes During Photoelectrochemical Water Oxidation on Catalyzed Hematite.

Qiu J, Hajibabaei H, Nellist MR, Laskowski FAL, Hamann TW, Boettcher SW.

ACS Cent Sci. 2017 Sep 27;3(9):1015-1025. doi: 10.1021/acscentsci.7b00310. Epub 2017 Aug 17.

11.

TSC2 c.1864C>T variant associated with mild cases of tuberous sclerosis complex.

Farach LS, Gibson WT, Sparagana SP, Nellist M, Stumpel CT, Hietala M, Friedman E, Pearson DA, Creighton SP, Wagemans A, Segel R, Ben-Shalom E, Au KS, Northrup H.

Am J Med Genet A. 2017 Mar;173(3):771-775. doi: 10.1002/ajmg.a.38083. Review.

PMID:
28211972
12.

Atomic force microscopy with nanoelectrode tips for high resolution electrochemical, nanoadhesion and nanoelectrical imaging.

Nellist MR, Chen Y, Mark A, Gödrich S, Stelling C, Jiang J, Poddar R, Li C, Kumar R, Papastavrou G, Retsch M, Brunschwig BS, Huang Z, Xiang C, Boettcher SW.

Nanotechnology. 2017 Mar 3;28(9):095711. doi: 10.1088/1361-6528/aa5839.

PMID:
28139467
13.

Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition.

Mateo F, Arenas EJ, Aguilar H, Serra-Musach J, de Garibay GR, Boni J, Maicas M, Du S, Iorio F, Herranz-Ors C, Islam A, Prado X, Llorente A, Petit A, Vidal A, Català I, Soler T, Venturas G, Rojo-Sebastian A, Serra H, Cuadras D, Blanco I, Lozano J, Canals F, Sieuwerts AM, de Weerd V, Look MP, Puertas S, García N, Perkins AS, Bonifaci N, Skowron M, Gómez-Baldó L, Hernández V, Martínez-Aranda A, Martínez-Iniesta M, Serrat X, Cerón J, Brunet J, Barretina MP, Gil M, Falo C, Fernández A, Morilla I, Pernas S, Plà MJ, Andreu X, Seguí MA, Ballester R, Castellà E, Nellist M, Morales S, Valls J, Velasco A, Matias-Guiu X, Figueras A, Sánchez-Mut JV, Sánchez-Céspedes M, Cordero A, Gómez-Miragaya J, Palomero L, Gómez A, Gajewski TF, Cohen EEW, Jesiotr M, Bodnar L, Quintela-Fandino M, López-Bigas N, Valdés-Mas R, Puente XS, Viñals F, Casanovas O, Graupera M, Hernández-Losa J, Ramón Y Cajal S, García-Alonso L, Saez-Rodriguez J, Esteller M, Sierra A, Martín-Martín N, Matheu A, Carracedo A, González-Suárez E, Nanjundan M, Cortés J, Lázaro C, Odero MD, Martens JWM, Moreno-Bueno G, Barcellos-Hoff MH, Villanueva A, Gomis RR, Pujana MA.

Oncogene. 2017 May 11;36(19):2737-2749. doi: 10.1038/onc.2016.427. Epub 2016 Dec 19.

14.

Interdependence of clinical factors predicting cognition in children with tuberous sclerosis complex.

Overwater IE, Verhaar BJ, Lingsma HF, Bindels-de Heus GC, van den Ouweland AM, Nellist M, Ten Hoopen LW, Elgersma Y, Moll HA, de Wit MC.

J Neurol. 2017 Jan;264(1):161-167. doi: 10.1007/s00415-016-8335-5. Epub 2016 Nov 22.

15.

Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin.

Dan HC, Sun M, Yang L, Feldman RI, Sui XM, Ou CC, Nellist M, Yeung RS, Halley DJ, Nicosia SV, Pledger WJ, Cheng JQ.

J Biol Chem. 2016 Oct 21;291(43):22848. No abstract available.

16.

TSC2 N-terminal lysine acetylation status affects to its stability modulating mTORC1 signaling and autophagy.

García-Aguilar A, Guillén C, Nellist M, Bartolomé A, Benito M.

Biochim Biophys Acta. 2016 Nov;1863(11):2658-2667. doi: 10.1016/j.bbamcr.2016.08.006. Epub 2016 Aug 16.

17.

Genotype and brain pathology phenotype in children with tuberous sclerosis complex.

Overwater IE, Swenker R, van der Ende EL, Hanemaayer KB, Hoogeveen-Westerveld M, van Eeghen AM, Lequin MH, van den Ouweland AM, Moll HA, Nellist M, de Wit MY.

Eur J Hum Genet. 2016 Dec;24(12):1688-1695. doi: 10.1038/ejhg.2016.85. Epub 2016 Jul 13.

18.

Novel Histopathological Patterns in Cortical Tubers of Epilepsy Surgery Patients with Tuberous Sclerosis Complex.

Mühlebner A, van Scheppingen J, Hulshof HM, Scholl T, Iyer AM, Anink JJ, van den Ouweland AM, Nellist MD, Jansen FE, Spliet WG, Krsek P, Benova B, Zamecnik J, Crino PB, Prayer D, Czech T, Wöhrer A, Rahimi J, Höftberger R, Hainfellner JA, Feucht M, Aronica E.

PLoS One. 2016 Jun 13;11(6):e0157396. doi: 10.1371/journal.pone.0157396. eCollection 2016.

19.

Semiconductor-Electrocatalyst Interfaces: Theory, Experiment, and Applications in Photoelectrochemical Water Splitting.

Nellist MR, Laskowski FA, Lin F, Mills TJ, Boettcher SW.

Acc Chem Res. 2016 Apr 19;49(4):733-40. doi: 10.1021/acs.accounts.6b00001. Epub 2016 Apr 1.

PMID:
27035051
20.

Structural Basis of the Interaction between Tuberous Sclerosis Complex 1 (TSC1) and Tre2-Bub2-Cdc16 Domain Family Member 7 (TBC1D7).

Qin J, Wang Z, Hoogeveen-Westerveld M, Shen G, Gong W, Nellist M, Xu W.

J Biol Chem. 2016 Apr 15;291(16):8591-601. doi: 10.1074/jbc.M115.701870. Epub 2016 Feb 18.

21.

Structure of the TBC1D7-TSC1 complex reveals that TBC1D7 stabilizes dimerization of the TSC1 C-terminal coiled coil region.

Gai Z, Chu W, Deng W, Li W, Li H, He A, Nellist M, Wu G.

J Mol Cell Biol. 2016 Jan 20. pii: mjw001. [Epub ahead of print]

PMID:
26798146
22.

Variants Within TSC2 Exons 25 and 31 Are Very Unlikely to Cause Clinically Diagnosable Tuberous Sclerosis.

Ekong R, Nellist M, Hoogeveen-Westerveld M, Wentink M, Panzer J, Sparagana S, Emmett W, Dawson NL, Malinge MC, Nabbout R, Carbonara C, Barberis M, Padovan S, Futema M, Plagnol V, Humphries SE, Migone N, Povey S.

Hum Mutat. 2016 Apr;37(4):364-70. doi: 10.1002/humu.22951. Epub 2016 Jan 12.

23.

PAK2 is an effector of TSC1/2 signaling independent of mTOR and a potential therapeutic target for Tuberous Sclerosis Complex.

Alves MM, Fuhler GM, Queiroz KC, Scholma J, Goorden S, Anink J, Spek CA, Hoogeveen-Westerveld M, Bruno MJ, Nellist M, Elgersma Y, Aronica E, Peppelenbosch MP.

Sci Rep. 2015 Sep 28;5:14534. doi: 10.1038/srep14534.

24.

Targeted Next Generation Sequencing reveals previously unidentified TSC1 and TSC2 mutations.

Nellist M, Brouwer RW, Kockx CE, van Veghel-Plandsoen M, Withagen-Hermans C, Prins-Bakker L, Hoogeveen-Westerveld M, Mrsic A, van den Berg MM, Koopmans AE, de Wit MC, Jansen FE, Maat-Kievit AJ, van den Ouweland A, Halley D, de Klein A, van IJcken WF.

BMC Med Genet. 2015 Feb 25;16:10. doi: 10.1186/s12881-015-0155-4.

25.

Germline activating AKT3 mutation associated with megalencephaly, polymicrogyria, epilepsy and hypoglycemia.

Nellist M, Schot R, Hoogeveen-Westerveld M, Neuteboom RF, van der Louw EJ, Lequin MH, Bindels-de Heus K, Sibbles BJ, de Coo R, Brooks A, Mancini GM.

Mol Genet Metab. 2015 Mar;114(3):467-73. doi: 10.1016/j.ymgme.2014.11.018. Epub 2014 Dec 5.

PMID:
25523067
26.

Preliminary functional assessment and classification of DEPDC5 variants associated with focal epilepsy.

van Kranenburg M, Hoogeveen-Westerveld M, Nellist M.

Hum Mutat. 2015 Feb;36(2):200-9. doi: 10.1002/humu.22723. Epub 2014 Nov 27.

PMID:
25366275
27.

Identification of regions critical for the integrity of the TSC1-TSC2-TBC1D7 complex.

Santiago Lima AJ, Hoogeveen-Westerveld M, Nakashima A, Maat-Kievit A, van den Ouweland A, Halley D, Kikkawa U, Nellist M.

PLoS One. 2014 Apr 8;9(4):e93940. doi: 10.1371/journal.pone.0093940. eCollection 2014.

28.

Clinical significance of immunohistochemistry for detection of BAP1 mutations in uveal melanoma.

Koopmans AE, Verdijk RM, Brouwer RW, van den Bosch TP, van den Berg MM, Vaarwater J, Kockx CE, Paridaens D, Naus NC, Nellist M, van IJcken WF, Kiliç E, de Klein A.

Mod Pathol. 2014 Oct;27(10):1321-30. doi: 10.1038/modpathol.2014.43. Epub 2014 Mar 14.

29.

Tubers from patients with tuberous sclerosis complex are characterized by changes in microtubule biology through ROCK2 signalling.

Ferrer I, Mohan P, Chen H, Castellsague J, Gómez-Baldó L, Carmona M, García N, Aguilar H, Jiang J, Skowron M, Nellist M, Ampuero I, Russi A, Lázaro C, Maxwell CA, Pujana MA.

J Pathol. 2014 Jul;233(3):247-57. doi: 10.1002/path.4343. Epub 2014 Apr 29. Erratum in: J Pathol. 2016 Jun;239(2):242.

PMID:
24604753
30.

5-Chloro-2-(thio-phen-2-yl)-1-(thio-phen-2-ylmeth-yl)-1H-benzimidazole-6-chloro-2-(thiophen-2-yl)-1-(thiophen-2-ylmethyl)-1H-benzimidazole (0.94/0.06).

Geiger DK, Nellist MR.

Acta Crystallogr Sect E Struct Rep Online. 2013 Sep 12;69(Pt 10):o1539-40. doi: 10.1107/S1600536813024999. eCollection 2013.

31.

6-Chloro-2-(thio-phen-2-yl)-1-[(thio-phen-2-yl)meth-yl]-1H-benzimidazole.

Geiger DK, Nellist MR.

Acta Crystallogr Sect E Struct Rep Online. 2013 Apr 30;69(Pt 5):o807. doi: 10.1107/S1600536813011124. Print 2013 May 1.

32.

TORC1-dependent epilepsy caused by acute biallelic Tsc1 deletion in adult mice.

Abs E, Goorden SM, Schreiber J, Overwater IE, Hoogeveen-Westerveld M, Bruinsma CF, Aganović E, Borgesius NZ, Nellist M, Elgersma Y.

Ann Neurol. 2013 Oct;74(4):569-79. doi: 10.1002/ana.23943. Epub 2013 Sep 10.

PMID:
23720219
33.

The TSC1-TSC2 complex consists of multiple TSC1 and TSC2 subunits.

Hoogeveen-Westerveld M, van Unen L, van den Ouweland A, Halley D, Hoogeveen A, Nellist M.

BMC Biochem. 2012 Sep 24;13:18. doi: 10.1186/1471-2091-13-18.

34.

Functional assessment of TSC2 variants identified in individuals with tuberous sclerosis complex.

Hoogeveen-Westerveld M, Ekong R, Povey S, Mayer K, Lannoy N, Elmslie F, Bebin M, Dies K, Thompson C, Sparagana SP, Davies P, van Eeghen AM, Thiele EA, van den Ouweland A, Halley D, Nellist M.

Hum Mutat. 2013 Jan;34(1):167-75. doi: 10.1002/humu.22202. Epub 2012 Oct 11. Erratum in: Hum Mutat. 2013 Feb;34(2):408-10. van Eeghen, Agnies M [added]; Thiele, Elizabeth A [added].

PMID:
22903760
35.

Central TSC2 missense mutations are associated with a reduced risk of infantile spasms.

van Eeghen AM, Nellist M, van Eeghen EE, Thiele EA.

Epilepsy Res. 2013 Jan;103(1):83-7. doi: 10.1016/j.eplepsyres.2012.07.007. Epub 2012 Aug 3.

PMID:
22867869
36.

Fetal brain lesions in tuberous sclerosis complex: TORC1 activation and inflammation.

Prabowo AS, Anink JJ, Lammens M, Nellist M, van den Ouweland AM, Adle-Biassette H, Sarnat HB, Flores-Sarnat L, Crino PB, Aronica E.

Brain Pathol. 2013 Jan;23(1):45-59. doi: 10.1111/j.1750-3639.2012.00616.x. Epub 2012 Aug 30.

37.

Functional assessment of TSC1 missense variants identified in individuals with tuberous sclerosis complex.

Hoogeveen-Westerveld M, Ekong R, Povey S, Karbassi I, Batish SD, den Dunnen JT, van Eeghen A, Thiele E, Mayer K, Dies K, Wen L, Thompson C, Sparagana SP, Davies P, Aalfs C, van den Ouweland A, Halley D, Nellist M.

Hum Mutat. 2012 Mar;33(3):476-9. doi: 10.1002/humu.22007. Epub 2012 Jan 17.

PMID:
22161988
38.

Functional characterization of the TSC2 c.3598C>T (p.R1200W) missense mutation that co-segregates with tuberous sclerosis complex in mildly affected kindreds.

Wentink M, Nellist M, Hoogeveen-Westerveld M, Zonnenberg B, van der Kolk D, van Essen T, Park SM, Woods G, Cohn-Hokke P, Brussel W, Smeets E, Brooks A, Halley D, van den Ouweland A, Maat-Kievit A.

Clin Genet. 2012 May;81(5):453-61. doi: 10.1111/j.1399-0004.2011.01648.x. Epub 2011 Mar 10.

PMID:
21332470
39.

Rheb is essential for murine development.

Goorden SM, Hoogeveen-Westerveld M, Cheng C, van Woerden GM, Mozaffari M, Post L, Duckers HJ, Nellist M, Elgersma Y.

Mol Cell Biol. 2011 Apr;31(8):1672-8. doi: 10.1128/MCB.00985-10. Epub 2011 Feb 14.

40.

Functional assessment of variants in the TSC1 and TSC2 genes identified in individuals with Tuberous Sclerosis Complex.

Hoogeveen-Westerveld M, Wentink M, van den Heuvel D, Mozaffari M, Ekong R, Povey S, den Dunnen JT, Metcalfe K, Vallee S, Krueger S, Bergoffen J, Shashi V, Elmslie F, Kwiatkowski D, Sampson J, Vidales C, Dzarir J, Garcia-Planells J, Dies K, Maat-Kievit A, van den Ouweland A, Halley D, Nellist M.

Hum Mutat. 2011 Apr;32(4):424-35. doi: 10.1002/humu.21451. Epub 2011 Mar 8.

PMID:
21309039
41.

Characterisation of TSC1 promoter deletions in tuberous sclerosis complex patients.

van den Ouweland AM, Elfferich P, Zonnenberg BA, Arts WF, Kleefstra T, Nellist MD, Millan JM, Withagen-Hermans C, Maat-Kievit AJ, Halley DJ.

Eur J Hum Genet. 2011 Feb;19(2):157-63. doi: 10.1038/ejhg.2010.156. Epub 2010 Sep 29.

42.

Analysis of TSC1 truncations defines regions involved in TSC1 stability, aggregation and interaction.

Hoogeveen-Westerveld M, Exalto C, Maat-Kievit A, van den Ouweland A, Halley D, Nellist M.

Biochim Biophys Acta. 2010 Sep;1802(9):774-81. doi: 10.1016/j.bbadis.2010.06.004. Epub 2010 Jun 12.

43.

Hamartin variants that are frequent in focal dysplasias and cortical tubers have reduced tuberin binding and aberrant subcellular distribution in vitro.

Lugnier C, Majores M, Fassunke J, Pernhorst K, Niehusmann P, Simon M, Nellist M, Schoch S, Becker A.

J Neuropathol Exp Neurol. 2009 Oct;68(10):1136-46. doi: 10.1097/NEN.0b013e3181b9a699.

PMID:
19918125
44.

Gene expression analysis of tuberous sclerosis complex cortical tubers reveals increased expression of adhesion and inflammatory factors.

Boer K, Crino PB, Gorter JA, Nellist M, Jansen FE, Spliet WG, van Rijen PC, Wittink FR, Breit TM, Troost D, Wadman WJ, Aronica E.

Brain Pathol. 2010 Jul;20(4):704-19. doi: 10.1111/j.1750-3639.2009.00341.x. Epub 2009 Oct 8.

45.

Identification of a region required for TSC1 stability by functional analysis of TSC1 missense mutations found in individuals with tuberous sclerosis complex.

Mozaffari M, Hoogeveen-Westerveld M, Kwiatkowski D, Sampson J, Ekong R, Povey S, den Dunnen JT, van den Ouweland A, Halley D, Nellist M.

BMC Med Genet. 2009 Sep 11;10:88. doi: 10.1186/1471-2350-10-88.

46.

A reliable cell-based assay for testing unclassified TSC2 gene variants.

Coevoets R, Arican S, Hoogeveen-Westerveld M, Simons E, van den Ouweland A, Halley D, Nellist M.

Eur J Hum Genet. 2009 Mar;17(3):301-10. doi: 10.1038/ejhg.2008.184. Epub 2008 Oct 15.

47.

Missense mutations to the TSC1 gene cause tuberous sclerosis complex.

Nellist M, van den Heuvel D, Schluep D, Exalto C, Goedbloed M, Maat-Kievit A, van Essen T, van Spaendonck-Zwarts K, Jansen F, Helderman P, Bartalini G, Vierimaa O, Penttinen M, van den Ende J, van den Ouweland A, Halley D.

Eur J Hum Genet. 2009 Mar;17(3):319-28. doi: 10.1038/ejhg.2008.170. Epub 2008 Oct 1.

48.

Cellular localization of metabotropic glutamate receptors in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex.

Boer K, Troost D, Timmermans W, Gorter JA, Spliet WG, Nellist M, Jansen F, Aronica E.

Neuroscience. 2008 Sep 22;156(1):203-15. doi: 10.1016/j.neuroscience.2008.06.073. Epub 2008 Jul 25.

PMID:
18706978
49.

Clinicopathological and immunohistochemical findings in an autopsy case of tuberous sclerosis complex.

Boer K, Troost D, Jansen F, Nellist M, van den Ouweland AM, Geurts JJ, Spliet WG, Crino P, Aronica E.

Neuropathology. 2008 Dec;28(6):577-90. doi: 10.1111/j.1440-1789.2008.00920.x. Epub 2008 Apr 11.

PMID:
18410267
50.

Functional characterisation of the TSC1-TSC2 complex to assess multiple TSC2 variants identified in single families affected by tuberous sclerosis complex.

Nellist M, Sancak O, Goedbloed M, Adriaans A, Wessels M, Maat-Kievit A, Baars M, Dommering C, van den Ouweland A, Halley D.

BMC Med Genet. 2008 Feb 26;9:10. doi: 10.1186/1471-2350-9-10.

Supplemental Content

Loading ...
Support Center